Initiation of the Phase 2 EMPOWER trial of ARD-201 for the treatment of obesity and obesity-related conditions as a fixed-dose combination of ARD-101 with a dipeptidyl peptidase-4 (DPP-4) inhibitor is ...
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...
39m
Mick Hitchcock, Ph.D., appointed Interim Chief Executive OfficerBiomea preparing icovamenib for late-stage clinical developmentMultiple milestones anticipated in 2025 including:FDA meeting anticipated ...
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial ...
Lawyers for a Florida death row inmate Michael Tanzi seek to delay his execution due to his morbid obesity, arguing that it ...
When presented with a vignette describing the behaviors and characteristics of a patient with disordered eating, only a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback